340B Drug Pricing Program
340B Drug Pricing Program is a federal program in the United States that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The program was established by the Veterans Health Care Act of 1992 and is managed by the Health Resources and Services Administration (HRSA).
Overview
The 340B Drug Pricing Program is named after Section 340B of the Public Health Service Act. The program allows certain hospitals and other health care providers, referred to as "covered entities," to purchase prescription drugs at discounted prices. The goal of the program is to enable these entities to "stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services."
Eligibility
Covered entities that can participate in the 340B Program include certain federal grantees, Federally Qualified Health Centers, and certain types of hospitals including Disproportionate Share Hospitals, children's hospitals, and cancer hospitals. These entities must be nonprofit and receive federal funding.
Operation
The 340B Program requires drug manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to covered entities. These entities can then provide the drugs to eligible patients, either directly or through contracted pharmacies. The program does not require the covered entities to pass the discounts on to patients, but many choose to do so.
Controversies
The 340B Program has been the subject of controversy and legal challenges. Critics argue that the program lacks transparency and oversight, and that some covered entities may be profiting from the discounts rather than passing them on to patients. Supporters of the program argue that it provides vital support to hospitals serving low-income and uninsured patients.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD